Patients’ perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trial
ABSTRACT: Objectives: Eosinophilic granulomatosis with polyangiitis (EGPA) is a complex, multisystem form of vasculitis. MANDARA (NCT04157348) was a phase 3 clinical trial comparing the efficacy and safety of benralizumab versus mepolizumab, in addition to standard of care, for relapsing/refractory...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier
2025-10-01
|
| Cyfres: | EULAR Rheumatology Open |
| Mynediad Ar-lein: | http://www.sciencedirect.com/science/article/pii/S3050708125000722 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
